$Pfizer(PFE)$ Worth mentioning again: France cancelled their order for Merck's Covid-19 anti-viral med. The move was prompted by the miserable 30% efficacy and a hope of getting PFE's entry before the end of January 2022. Can you say unbridled demand?
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
点赞
举报
登录后可参与评论
暂无评论